Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
The outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment, is the largest manufacturing investment in company history.
Ozempic Slows Kidney Disease, Novo Nordisk Study Finds
Novo Nordisk's Ozempic drug slows the progression of chronic kidney disease and cuts the risk of kidney failure, heart attack, stroke and death in patients with Type 2 diabetes, a long-term trial showed.
Hoka Sales Show Just How Big a Problem Nike Really Has
Hoka sales of $533 million jump 34% from the previous year. Deckers Outdoor tops fourth-quarter earnings estimates.
Lucid Group Is Cutting 6% of Its Workforce. The Stock Is Down.
The electric-vehicle start-up says the job cuts are part of a restructuring plan to optimize its operating expenses.
Workday earnings add to view that chip stocks trump software stocks now
Workday's stock is falling as analysts wonder whether the recent guidance cut is the final one.
Sony's Entertainment Unit Syncs Up for Success, Paramount or Not
Sony is aiming to make better use of intellectual property across gaming, films and more.
Nvidia Is Now Worth More Than Amazon and Tesla Combined
After blowout earnings, the chip maker's market cap has surged to $2.59 trillion.
Why T.J. Maxx and Ross Stores Shares Command Full Price
Off-price retailers TJX Cos. and Ross Stores have piles of deals for bargain hunters. Their stocks are a different story.
U.S. Real-Estate Fund Details Limits to Investor Redemptions
Starwood Real Estate Income Trust is tightening its redemption policies for investors as it slows its real-estate asset sales amid depressed prices.
Jeep and Ram Dealers Gripe to Stellantis as Cars Sit on Lots
The automaker is cutting prices and launching an unusual incentive program following a meeting with retailers.
(END) Dow Jones Newswires
05-24-24 1115ET
